HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) EVP Michael Henry Fiore sold 8,881 shares of the company's stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. The trade was a 13.55 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
HealthEquity Stock Performance
Shares of NASDAQ HQY traded up $2.26 during trading on Friday, reaching $82.20. 926,462 shares of the company traded hands, compared to its average volume of 759,548. The firm has a 50 day simple moving average of $97.63 and a 200-day simple moving average of $96.30. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The stock has a market capitalization of $7.11 billion, a PE ratio of 75.41, a P/E/G ratio of 1.60 and a beta of 0.49. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.
Institutional Investors Weigh In On HealthEquity
Several institutional investors and hedge funds have recently added to or reduced their stakes in HQY. Congress Asset Management Co. boosted its stake in shares of HealthEquity by 168.0% during the 1st quarter. Congress Asset Management Co. now owns 68,253 shares of the company's stock worth $6,032,000 after acquiring an additional 42,785 shares during the last quarter. Radnor Capital Management LLC lifted its stake in HealthEquity by 6.2% in the 1st quarter. Radnor Capital Management LLC now owns 6,040 shares of the company's stock worth $534,000 after purchasing an additional 350 shares in the last quarter. Chesley Taft & Associates LLC boosted its holdings in shares of HealthEquity by 44.7% during the 1st quarter. Chesley Taft & Associates LLC now owns 12,622 shares of the company's stock valued at $1,115,000 after purchasing an additional 3,897 shares during the last quarter. Portside Wealth Group LLC purchased a new position in shares of HealthEquity during the first quarter valued at about $225,000. Finally, Hennion & Walsh Asset Management Inc. grew its position in shares of HealthEquity by 40.0% during the first quarter. Hennion & Walsh Asset Management Inc. now owns 3,137 shares of the company's stock valued at $277,000 after purchasing an additional 897 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.
Analyst Upgrades and Downgrades
HQY has been the topic of a number of recent research reports. KeyCorp cut their price objective on shares of HealthEquity from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Monday, March 24th. The Goldman Sachs Group reduced their price objective on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their target price for the stock from $120.00 to $115.00 in a report on Tuesday, March 25th. Barrington Research restated an "outperform" rating and set a $112.00 price target on shares of HealthEquity in a report on Friday. Finally, Wells Fargo & Company upped their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, HealthEquity currently has an average rating of "Buy" and an average target price of $112.58.
Read Our Latest Stock Report on HQY
About HealthEquity
(
Get Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Stories

Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.